Clinical Trial Update: Molecularly Target Therapy With GEMOX in Advanced or Recurrent Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma [Phase 2]

View source ↗

Summary

This report covers a Phase 2 trial of GEMOX (gemcitabine plus oxaliplatin) for advanced or recurrent extrahepatic cholangiocarcinoma and gallbladder cancer, wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extrahepatic Cholangiocarcinoma
• Gallbladder Cancer

Drugs mentioned

• Gemcitabine (Gemcitabine)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Shanghai Jiao Tong University School of Medicine | Conditions: Cholangiocarcinoma of the Extrahepatic Bile Duct, Gallbladder Cancer | Phase 2 | Status: UNKNOWN